Bayer And Novartis Lose Challenge To NHS Eye Drug Policy
The Court of Appeal ruled Wednesday that a policy from certain NHS groups offering an off-label drug for treatment of an eye disorder was lawful, rejecting Bayer and Novartis' arguments that permitting use...To view the full article, register now.
Already a subscriber? Click here to view full article